If you're a growth investor then you're in luck. This is because the Australian share market is home to a large number of quality shares that have the potential to grow very strongly in the coming years.
Five top growth shares I would buy in September are listed below. Here's why I like them:
Afterpay Ltd (ASX: APT)
I believe this payments company could be a strong performer over the 2020s. Especially given the incredible active customer growth it is experiencing in the United Kingdom and United States markets. This should be supported by expansions into Europe and Asia in the coming years.
Altium Limited (ASX: ALU)
I believe Altium can grow its revenue and earnings at a very strong rate over the next few years. This is thanks to its industry-leading Altium Designer product and its exposure to the rapidly growing Internet of Things and Artificial Intelligence markets. Together with its other growing businesses, I believe Altium will dominate its industry by 2025/26.
Appen Ltd (ASX: APX)
Another top growth share to buy right now is Appen. It is a fast-growing developer of high-quality training data for machine learning and artificial intelligence. I expect the growing importance of artificial intelligence for businesses and governments to lead to a sustained increase in demand for its services over the 2020s.
Pushpay Holdings Group Ltd (ASX: PPH)
A fourth growth share to look at is Pushpay. It is a growing donor management and community engagement platform provider for the church market. Pushpay has been growing its earnings at a rapid rate over the last couple of years and looks well-positioned to continue this trend for some time to come. Management is aiming to win a 50% share of the medium to large church market in the future. This represents a US$1 billion opportunity and is many times greater than its current revenue.
ResMed Inc. (ASX: RMD)
A final growth share to look at is ResMed. Due to the growing demand for its industry-leading products in the fast-growing sleep treatment market, I expect it to continue its solid growth for the foreseeable future. In light of this, I believe the ResMed share price can continue to be a market beater over the 2020s.
